Ertugliflozin L-pyroglutamic Acid
Ertugliflozin L-pyroglutamic acid (PF-04971729 L-pyroglutamic acid) is a potent, selective and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2), with an IC50 of 0.877 nM for h-SGLT2[1]. A drug for the treatment of type 2 diabetes mellitus[2].
| Trivial name | / |
| Catalog Number | CSN23815 |
| Alternative Name(s) | / |
| Research Area | Metabolic Disease |
| Molecular Formula | C27H32ClNO10 |
| CAS# | 1210344-83-4 |
| Purity | ≥99% |
| SMILES | OC[C@]12CO[C@](O2)(C3=CC(CC4=CC=C(OCC)C=C4)=C(Cl)C=C3)[C@H](O)[C@@H](O)[C@@H]1O.O=C5N[C@H](C(O)=O)CC5 |
| Size | 5mg |
| Supplier Page | https://www.csnpharm.com/products/ertugliflozin-l-pyroglutamic-acid.html |